| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 10/05/1999 | CA2111336C Broad spectrum antimicrobial compounds and methods of use |
| 09/30/1999 | WO1999049026A1 Bacteria attenuated by a non-reverting mutation in each of the aroc, ompf and ompc genes, useful as vaccines |
| 09/30/1999 | WO1999049017A2 Mutations responsible for attenuation in measles virus or human respiratory syncytial virus subgroup b |
| 09/30/1999 | WO1999048917A2 Formulation having a papilloma virus-specific protein, and the production and use thereof |
| 09/30/1999 | WO1999048902A1 Azt derivatives exhibiting spermicidal and anti-viral activity |
| 09/30/1999 | WO1999048896A1 Cephalosporines having cyclic aminoguanidine substituents as antibiotics |
| 09/30/1999 | WO1999048885A1 Process for the synthesis of hiv protease inhibitors |
| 09/30/1999 | WO1999048536A2 Delivery of long lasting therapeutic agents by forming covalent attachments in vivo |
| 09/30/1999 | WO1999048535A1 Formulations for protection of peg-interferon alpha conjugates |
| 09/30/1999 | WO1999048526A1 METHOD OF RENDERING A HUMAN IMMUNODEFICIENCY VIRUS POPULATION REPLICATION INCOMPETENT $i(IN VIVO) |
| 09/30/1999 | WO1999048525A1 Hib/dtpa vaccine composition and methods of preparation |
| 09/30/1999 | WO1999048511A1 Antifungal and antibacterial compositions containing melaleuca essential oil |
| 09/30/1999 | WO1999048471A1 Polyalkoxy copolymers as lipase inhibitors and their compositions |
| 09/30/1999 | WO1999048461A2 Substituted aromatic compounds for treatment of antibiotic resistant infections |
| 09/30/1999 | WO1999048361A1 Xylitol compositions for treating upper respiratory conditions |
| 09/30/1999 | WO1999042478A3 LEPTOSPIRAL OUTER MEMBRANE PROTEIN, LipL32 |
| 09/30/1999 | WO1999036410A9 Triazine antiviral compounds |
| 09/30/1999 | WO1999035246A9 Novel steroid-activated nuclear receptors and uses therefor |
| 09/30/1999 | WO1999031122A9 Antipicornaviral compounds and methods for their use and preparation |
| 09/30/1999 | WO1999006340A3 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors |
| 09/30/1999 | CA2325689A1 Substituted aromatic compounds for treatment of antibiotic resistant infections |
| 09/30/1999 | CA2325460A1 Azt derivatives exhibiting spermicidal and anti-viral activity |
| 09/30/1999 | CA2325436A1 Vaccine composition |
| 09/30/1999 | CA2323927A1 Mutations responsible for attenuation in measles virus or human respiratory syncytial virus subgroup b |
| 09/30/1999 | CA2323526A1 Formulation having a papilloma virus-specific protein, and the production and use thereof |
| 09/30/1999 | CA2291066A1 Local delivery of long lasting therapeutic agents |
| 09/30/1999 | CA2264951A1 Amino acid derivatives |
| 09/29/1999 | EP0945461A1 Lipopeptides inducing T-cyxtotoxic lymphocytes and their use as vaccines |
| 09/29/1999 | EP0945443A1 HIV inhibiting pyrimidine derivatives |
| 09/29/1999 | EP0944724A1 USE OF A VECTOR EXPRESSING DNA POLYMERASE $g(b) AS MEDICINE |
| 09/29/1999 | EP0944645A1 INHIBITORS OF INTERLEUKIN-1beta CONVERTING ENZYME |
| 09/29/1999 | EP0944630A1 Xanthines and their therapeutic use |
| 09/29/1999 | EP0944616A1 Bicyclic aryl carboxamides and their therapeutic use |
| 09/29/1999 | EP0944610A1 Asymmetric synthesis of benzoxazinones |
| 09/29/1999 | EP0944394A1 Treatment of hiv-infection by interfering with host cell cyclophilin receptor activity |
| 09/29/1999 | EP0944388A2 Inhibitors of farnesyl-protein transferase |
| 09/29/1999 | EP0944385A2 USE OF 7-(1-AMINOMETHYL-2-OXA-7-AZA-BICYCLO 3.3.0]OCT-7-YL)-QUINOLONE CARBOXYLIC ACID AND NAPHTHYRIDONE CARBOXYLIC ACID DERIVATIVES FOR TREATING $i(HELICOBACTER PYLORI) INFECTIONS AND THE GASTRODUODENAL DISEASES ASSOCIATED THEREWITH |
| 09/29/1999 | EP0714307B1 Vaccine compositions |
| 09/29/1999 | EP0711140B1 Antifungal nail solution |
| 09/29/1999 | EP0630216B1 Adhesive bandage |
| 09/29/1999 | EP0591281B1 Immunogen compounds having specifically an anti-cytokine effect, method of preparation, pharmaceutical compositions and kits containing them |
| 09/29/1999 | EP0586663B1 Carbapenem derivatives as antibiotics and intermediates thereof |
| 09/29/1999 | EP0553107B1 Protein kinase c modulators with anti-inflammatory and antiviral activity |
| 09/29/1999 | CN1230198A Therapeutic multispecific compounds comprised of anti-FC'alpha' receptor antibodies |
| 09/29/1999 | CN1230197A Subunit respiratory syncytial virus vaccine prepn. |
| 09/29/1999 | CN1230196A Modified aminoacids, pharmaceuticals containing these compounds and method for their prodn. |
| 09/29/1999 | CN1230195A Treatment of immune disorders |
| 09/29/1999 | CN1230120A Compounds that inhibit interaction between signal-transducing proteins and GLGF(PDZ/DHR) domain and uses thereof |
| 09/29/1999 | CN1230117A Pharmaceutical compsns. with antimicrobial activity |
| 09/29/1999 | CN1230116A Pharmaceutical compsn. for treating viral diseases |
| 09/28/1999 | US5959145 12-(methoxy)dodecanoic acid. |
| 09/28/1999 | US5959123 Reacating substituted amino acid with 3-amino-4-substituted-azetidine-2-one compound to form 3, 4-disubstituted-azetidine-2-one compound; useful for treating muscular dystrophy, arthritis, viral and parasitic infections |
| 09/28/1999 | US5958983 Novel compounds having antiviral activity against herpes, topical administration them to treat patients with herpes; work by inhibiting the initiation of herpes viral dna synthesis in host cells |
| 09/28/1999 | US5958975 Antiodor, antimicrobial and preservative compositions and methods of using same |
| 09/28/1999 | US5958953 Substituted indazole derivatives |
| 09/28/1999 | US5958943 A!-anellated pyrrole derivatives and their use in pharmacology |
| 09/28/1999 | US5958914 For the treatment of bacterial infectious diseases |
| 09/28/1999 | US5958910 Use of N-(4-aryl-thiazol-2-yl)-sulfonamides |
| 09/28/1999 | US5958895 Delivering to a mammalian cell an effective amount of a modified gene encoding an hsv gd antigen lacking a functional native signal peptide, said modified gene under the control of regulatory sequences directing expression of said antigen |
| 09/28/1999 | US5958887 Use of a hymenoptera venom for the manufacture of a medicament for treating DNA virus infections |
| 09/28/1999 | US5958772 Antisense inhibition of cellular inhibitor of apoptosis-1 expression |
| 09/28/1999 | US5958765 For producing human monoclonal antibodies which are specific to respiratory syncytial virus and in particular the rsv fusion (f) protein |
| 09/28/1999 | US5958425 Viral vaccines |
| 09/28/1999 | US5958424 Recombinant chicken anemia virus particle |
| 09/28/1999 | US5958423 Vaccine for immunizing animal against infection by bovine respiratory syncytial virus |
| 09/28/1999 | US5958422 Containing a foreign peptide insert in the coat protein of the virus; for use in vaccines |
| 09/28/1999 | US5958414 An isolated bartionella henselae antigen comprising whole inactivated bartionella henselae cells and an adjuvant comprising poly(di(carboxylatophenoxy)phosphazene; culture product |
| 09/28/1999 | US5958401 Method of using IL-11 for treating psoriasis |
| 09/28/1999 | US5958400 Isolated polypeptide comprising specified amino acid sequence |
| 09/28/1999 | CA2181351C Process and intermediates for preparing naphthyridonecarboxylic acid salts |
| 09/28/1999 | CA2072095C Outer membrane protein p1 and peptides of haemophilus influenzae type b |
| 09/28/1999 | CA1340773C Anti-neoplastic, anti-viral or anti-retoviral sperime derivative |
| 09/26/1999 | CA2264260A1 Polynucleotide molecules encoding neospora proteins |
| 09/23/1999 | WO1999047929A1 Development of human monoclonal antibodies and uses thereof |
| 09/23/1999 | WO1999047927A1 An equine neospora isolate and its uses |
| 09/23/1999 | WO1999047707A1 Antisense modulation of lfa-3 |
| 09/23/1999 | WO1999047672A1 Modulators of the function of receptors of the tnf/ngf receptor family and other proteins |
| 09/23/1999 | WO1999047662A1 Staphylococcus aureus genes and polypeptides |
| 09/23/1999 | WO1999047645A1 Process for the production of virus in cell cultures |
| 09/23/1999 | WO1999047639A2 Staphylococcus aureus genes and polypeptides |
| 09/23/1999 | WO1999047553A2 Bacterial yeal family members as targets for antimicrobial drug design |
| 09/23/1999 | WO1999047551A1 Wf14573 or its salt, production thereof and use thereof |
| 09/23/1999 | WO1999047545A2 Inhibitors of caspases |
| 09/23/1999 | WO1999047544A1 nrdF |
| 09/23/1999 | WO1999047538A1 Cytokine receptor common gamma chain like |
| 09/23/1999 | WO1999047537A1 Staphylococcus aureus spo0j2: polynucleotide and protein |
| 09/23/1999 | WO1999047512A1 2-(2,6-dioxopiperidin-3-yl)isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines |
| 09/23/1999 | WO1999047507A2 1,3,4-thiadiazoles useful for the treatment of cmv infections |
| 09/23/1999 | WO1999047501A2 Nonnucleoside inhibitors of reverse transcriptase for the treatment of hiv-infection |
| 09/23/1999 | WO1999047173A2 Carrier for in vivo delivery of a therapeutic agent |
| 09/23/1999 | WO1999047155A1 Preventives and/or remedies for sepsis |
| 09/23/1999 | WO1999047147A1 nrdG |
| 09/23/1999 | WO1999047140A1 Topical antiseptic compositions and methods |
| 09/23/1999 | WO1999041369A3 Genetic vaccine vector engineering |
| 09/23/1999 | WO1999038524A3 Therapeutic administration of low density lipoprotein receptor for viral infections and immune regulation |
| 09/23/1999 | WO1998015284A3 Mycosis vaccines |
| 09/23/1999 | CA2625284A1 Modulators of the function of receptors of the tnf/ngf receptor family |
| 09/23/1999 | CA2323784A1 Carrier for in vivo delivery of a therapeutic agent |
| 09/23/1999 | CA2323724A1 Staphylococcus aureus genes and polypeptides |
| 09/23/1999 | CA2323637A1 Modulators of the function of receptors of the tnf/ngf receptor family and other proteins |